Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines. Nishida-Fukuda H, Tokuhiro K, Ando Y, Matsushita H, et al. PLoS One 2021;16:e0249912.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nishida-Fukuda H, Tokuhiro K, Ando Y, Matsushita H, et al. Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines. PLoS One 2021;16:e0249912.
PMID: 33852630